These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 10323422)
1. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Valk PE; Abella-Columna E; Haseman MK; Pounds TR; Tesar RD; Myers RW; Greiss HB; Hofer GA Arch Surg; 1999 May; 134(5):503-11; discussion 511-3. PubMed ID: 10323422 [TBL] [Abstract][Full Text] [Related]
2. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels. Ozkan E; Soydal C; Araz M; Kir KM; Ibis E Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859 [TBL] [Abstract][Full Text] [Related]
3. Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer. Sarikaya I; Povoski SP; Al-Saif OH; Kocak E; Bloomston M; Marsh S; Cao Z; Murrey DA; Zhang J; Hall NC; Knopp MV; Martin EW World J Surg Oncol; 2007 Jul; 5():80. PubMed ID: 17634125 [TBL] [Abstract][Full Text] [Related]
4. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers. Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416 [TBL] [Abstract][Full Text] [Related]
5. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. Metser U; You J; McSweeney S; Freeman M; Hendler A AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157 [TBL] [Abstract][Full Text] [Related]
6. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study. Ozkan E; Soydal C; Araz M; Aras G Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225 [TBL] [Abstract][Full Text] [Related]
7. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969 [TBL] [Abstract][Full Text] [Related]
8. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels. Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560 [TBL] [Abstract][Full Text] [Related]
9. DIAGNOSTIC ROLE OF FLUORINE-18 (18F) FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY IN DETECTING RECURRENT DISEASE IN PATIENTS WITH COLORECTAL CANCER AND ELEVATED CARCINOEMBRYONIC ANTIGEN. Matovina E; Mihailović J; Nikoletić K; Srbovan D Med Pregl; 2015; 68(11-12):376-81. PubMed ID: 26939303 [TBL] [Abstract][Full Text] [Related]
10. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer. Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer]. Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351 [TBL] [Abstract][Full Text] [Related]
12. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging. Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904 [TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities. Salem SS; Shahin MA Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387 [TBL] [Abstract][Full Text] [Related]
14. Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer. Liong SY; Kochhar R; Renehan AG; Manoharan P ANZ J Surg; 2012 Oct; 82(10):729-36. PubMed ID: 22989147 [TBL] [Abstract][Full Text] [Related]
15. (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. Chen LB; Tong JL; Song HZ; Zhu H; Wang YC World J Gastroenterol; 2007 Oct; 13(37):5025-9. PubMed ID: 17854148 [TBL] [Abstract][Full Text] [Related]
16. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Flanagan FL; Dehdashti F; Ogunbiyi OA; Kodner IJ; Siegel BA Ann Surg; 1998 Mar; 227(3):319-23. PubMed ID: 9527052 [TBL] [Abstract][Full Text] [Related]
17. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations. Kyoto Y; Momose M; Kondo C; Itabashi M; Kameoka S; Kusakabe K Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373 [TBL] [Abstract][Full Text] [Related]
18. FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA. Sarikaya I; Bloomston M; Povoski SP; Zhang J; Hall NC; Knopp MV; Martin EW World J Surg Oncol; 2007 Jun; 5():64. PubMed ID: 17555577 [TBL] [Abstract][Full Text] [Related]
19. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ogunbiyi OA; Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Birnbaum EH; Fleshman JW; Read TE; Philpott GW; Kodner IJ Ann Surg Oncol; 1997 Dec; 4(8):613-20. PubMed ID: 9416407 [TBL] [Abstract][Full Text] [Related]
20. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence. Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]